A small discovery about 1194-22-5

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Application In Synthesis of 6-Hydroxy-2-methylpyrimidin-4(3H)-one, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Application In Synthesis of 6-Hydroxy-2-methylpyrimidin-4(3H)-one. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 6-Hydroxy-2-methylpyrimidin-4(3H)-one, is researched, Molecular C5H6N2O2, CAS is 1194-22-5, about The nitration peculiarity of 6-hydroxy-2-methylpyrimidine-4(3H)-one to 6-hydroxy-2-methyl-5-nitropyrimidine-4(3H)-one. Author is Kushtaev, A. A.; Yudin, N. V.; Zbarsky, V. L..

The nitration kinetic of 6-hydroxy-2-methylpyrimidine-4(3H)-one to 6-hydroxy-2-methyl-5-nitropyrimidine-4(3H)-one was studied in sulfuric-nitric acid mixtures The dependences of rate constants from medium acidity and nitric acid concentration were obtained. The nitrogen oxides influence was discovered on this process. The basicity constant of 6-hydroxy-2-methylpyrimidine-4(3H)-one was calculated.

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Application In Synthesis of 6-Hydroxy-2-methylpyrimidin-4(3H)-one, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Extracurricular laboratory: Synthetic route of 288-42-6

If you want to learn more about this compound(Oxazole)Synthetic Route of C3H3NO, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 288-42-6, is researched, Molecular C3H3NO, about Fragment-Based Ligand Discovery Using Protein-Observed 19F NMR: A Second Semester Organic Chemistry CURE Project, the main research direction is chem laboratory research fluorine 19 NMR spectroscopy ligand discovery.Synthetic Route of C3H3NO.

Curriculum-based undergraduate research experiences (CUREs) have been shown to increase student retention in STEM fields and are starting to become more widely adopted in chem. curricula. Here we describe a 10-wk CURE that is suitable for a second-semester organic chem. laboratory course. Students synthesize small mols. and use protein-observed 19F (PrOF) NMR to assess the small mol.’s binding affinity to a target protein. The research project introduced students to multistep organic synthesis, structure-activity relationship studies, quant. biophys. measurements (measuring Kd from PrOF NMR experiments), and scientific literacy. Docking experiments could be added to help students understand how changes in a ligand structure may affect binding to a protein. Assessment using the CURE survey indicates self-perceived skill gains from the course that exceed gains measured in a traditional and an inquiry-based laboratory experience. Given the speed of the binding experiment and the alignment of the synthetic methods with a second-semester organic chem. laboratory course, a PrOF NMR fragment-based ligand discovery lab can be readily implemented in the undergraduate chem. curriculum.

If you want to learn more about this compound(Oxazole)Synthetic Route of C3H3NO, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Brief introduction of 288-42-6

If you want to learn more about this compound(Oxazole)HPLC of Formula: 288-42-6, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Metelytsia, Larysa O.; Trush, Maria M.; Kovalishyn, Vasyl V.; Hodyna, Diana M.; Kachaeva, Maryna V.; Brovaret, Volodymyr S.; Pilyo, Stepan G.; Sukhoveev, Volodymyr V.; Tsyhankov, Serhii A.; Blagodatnyi, Volodymyr M.; Semenyuta, Ivan V. researched the compound: Oxazole( cas:288-42-6 ).HPLC of Formula: 288-42-6.They published the article 《1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents》 about this compound( cas:288-42-6 ) in Computational Biology and Chemistry. Keywords: Candida cytisine oxazole derivative glutathione reductase mol docking; 1,3-oxazole; Candida spp.; Cytisine; Glutathione reductase; Molecular docking; QSAR. We’ll tell you more about this compound (cas:288-42-6).

Natural products as well as their derivatives play a significant role in the discovery of new biol. active compounds in the different areas of our life especially in the field of medicine. The synthesis of compounds produced from natural products including cytisine is one approach for the wider use of natural substances in the development of new drugs. QSAR modeling was used to predict and select of biol. active cytisine-containing 1,3-oxazoles. The eleven most promising compounds were identified, synthesized and tested. The activity of the synthesized compounds was evaluated using the disk diffusion method against C. albicans M 885 (ATCC 10,231) strain and clin. fluconazole-resistant Candida krusei strain. Mol. docking of the most active compounds as potential inhibitors of the Candida spp. glutathione reductase was performed using the AutoDock Vina. The built classification models demonstrated good stability, robustness and predictive power. The eleven cytisine-containing 1,3-oxazoles were synthesized and their activity against Candida spp. was evaluated. Compounds 10, 11 as potential inhibitors of the Candida spp. glutathione reductase demonstrated the high activity against C. albicans M 885 (ATCC 10,231) strain and clin. fluconazole-resistant Candida krusei strain. The studied compounds 10, 11 present the interesting scaffold for further investigation as potential inhibitors of the Candida spp. glutathione reductase with the promising antifungal properties. The developed models are publicly available online at http://ochem.eu/article/120720 and could be used by scientists for design of new more effective drugs.

If you want to learn more about this compound(Oxazole)HPLC of Formula: 288-42-6, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Let`s talk about compounds: 1194-22-5

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Recommanded Product: 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: 6-Hydroxy-2-methylpyrimidin-4(3H)-one, is researched, Molecular C5H6N2O2, CAS is 1194-22-5, about Properties of the OH Adducts of Hydroxy-, Methyl-, Methoxy-, and Amino-Substituted Pyrimidines: Their Dehydration Reactions and End-Product Analysis.Recommanded Product: 1194-22-5.

Reactions of hydroxyl radicals (•OH) with 2-amino-4-methylpyrimidine (AMP), 2-amino-4,6-dimethylpyrimidine (ADMP), 2-amino-4-methoxy-6-methylpyrimidine (AMMP), 2-amino-4-hydroxy-6-methylpyrimidine (AHMP), 4,6-dihydroxy-2-methylpyrimidine (DHMP), 2,4-dimethyl-6-hydroxypyrimidine (DMHP), 6-methyluracil (MU), and 5,6-dimethyluracil (DMU) have been studied by pulse radiolysis and steady-state radiolysis techniques at different pH values. The second-order rate constants of the reaction of •OH with these systems are of the order of (2-9) × 109 dm3 mol-1 s-1 at near neutral pH. The difference in the spectral features of the intermediates at near neutral pH and at higher pH (10.4) obtained with these pyrimidines are attributed to the deprotonation of the OH adducts. The G(TMPD•+) obtained at pH ∼ 6, from the electron-transfer reactions of the oxidizing intermediates with the reductant, N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD), are in the range (0.2-0.9) × 10-7 mol J-1 which constituted about 3-16% oxidizing radicals. These yields were highly enhanced at pH 10.5 in the case of AHMP, DHMP, DMU, and MU [G(TMPD•+) = 3.8-5.5 equivalent 66-95% oxidizing radical]. On the basis of these results, it is proposed that a nonoxidizing C(6)-ylC(5)OH radical adduct is initially formed at pH 6 which is responsible for the observed transient spectra. The high yield of TMPD•+ at higher pH is explained in terms of a base-catalyzed conversion (via a dehydration reaction) of the initially formed C(6)-ylC(5)OH adduct (nonoxidizing) to C(5)-ylC(6)OH adduct which is oxidizing in nature. Among the selected pyrimidines, such a dehydration reaction was observed only with those having a keto (or hydroxy) group at the C(4) position of the pyrimidine ring. Qual. analyses of the products resulting from the OH adducts of DHMP (at pH 4.5) and DMHP (at pH 6) were carried out using HPLC-ES-MS and a variety of products have been identified. Glycolic and dimeric products were observed as the major end-products. The product profiles of both DHMP and DMHP have shown that the precursors of the products are mainly the C(6)-ylC(5)OH and the H adduct radicals. The identified products are formed mainly by disproportionation and dimerization reactions of these radicals. The mechanistic aspects are discussed.

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Recommanded Product: 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

The origin of a common compound about 1194-22-5

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Recommanded Product: 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Synthetic modification and scale-up process for 1,1-diamino-2,2-dinitroethene (FOX-7)》. Authors are Chung, Kyoo-Hyun; Goh, Eun Mee; Cho, Jin Rai.The article about the compound:6-Hydroxy-2-methylpyrimidin-4(3H)-onecas:1194-22-5,SMILESS:CC1=NC(=CC(N1)=O)O).Recommanded Product: 1194-22-5. Through the article, more information about this compound (cas:1194-22-5) is conveyed.

Many different synthetic routes to FOX-7 were developed until now. Each starting material such as 2-methylimidazole, 2-methoxy-2-methylimidazolidine-4,5-dione, or 2-methylpyrimidine-4,6-dione (4,6-dihydroxy-2-methylpyrimidine), was nitrated and then hydrolyzed to FOX-7 by somewhat different process, but the yields were more or less low and the processes were felt a little boring. In the modified process from 4,6-dihydroxy-2-methylpyrimidine, FOX-7 was synthesized in about 90% yield within several hours. The reaction temperature was well controlled in the preparation of 4,6-dihydroxy-2-methylpyrimidine, while some heat was evolved at the beginning of nitration, judging from a reaction calorimeter.

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Recommanded Product: 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Simple exploration of 70-23-5

If you want to learn more about this compound(Ethyl 3-bromo-2-oxopropanoate)Application In Synthesis of Ethyl 3-bromo-2-oxopropanoate, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(70-23-5).

Application In Synthesis of Ethyl 3-bromo-2-oxopropanoate. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: Ethyl 3-bromo-2-oxopropanoate, is researched, Molecular C5H7BrO3, CAS is 70-23-5, about Syntheses of Novel Tetrasubstituted Thiophenes from Benzene-1,2-Diamines, Ethyl Bromopyruvate, Malononitrile, and Aryl Isothiocyanates. Author is Piltan, Mohammad.

Synthesis of amino(oxo-dihydroquinoxalinyl)(phenylamino)thiophene-carbonitrile derivatives I [R = H, Me, Cl; R1 = 2-MeOC6H4, 4-NO2C6H4, Et, Ph] was reported via sequential base mediated condensation of malononitrile with aryl isothiocyanates followed by S-alkylation with 3-(bromomethyl)quinoxalin-2(1H)-one compounds and concurrent intramol. enamine type condensation of S-alkylated compounds in excellent yields.

If you want to learn more about this compound(Ethyl 3-bromo-2-oxopropanoate)Application In Synthesis of Ethyl 3-bromo-2-oxopropanoate, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(70-23-5).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Simple exploration of 1194-22-5

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Related Products of 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Patil, R. S.; Jadhav, P. M.; Radhakrishnan, S.; Soman, T. published the article 《Process chemistry of 4, 6-dihydroxy-2-methylpyrimidine-A potential precursor in pharmaceutical and explosive industries》. Keywords: dihydroxy methylpyrimidine A pharmaceutical explosive industry.They researched the compound: 6-Hydroxy-2-methylpyrimidin-4(3H)-one( cas:1194-22-5 ).Related Products of 1194-22-5. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:1194-22-5) here.

4,6-Dihydroxy-2-methylpyrimidine is an important precursor, finding widespread applications in the preparation of high explosives and medicinal products. The synthesis of 4,6-dihydroxy-2-methylpyrimidine has been carried out by the condensation of acetamidinium chloride and di-Et malonate in absolute methanol and further acidified by hydrochloric acid. Process chem. has been studied by using various alcs., alkoxides and effect of reaction period. The role of process variables and parameters has been understood thoroughly and developed an economic process. Modified process yielded the product without compromising on its quality, which was confirmed by spectroscopic techniques and elemental anal. Hence, the study finds its usefulness in the development of an economic process for the production of 4,6-dihydroxy-2-methylpyrimidine.

If you want to learn more about this compound(6-Hydroxy-2-methylpyrimidin-4(3H)-one)Related Products of 1194-22-5, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(1194-22-5).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Archives for Chemistry Experiments of 5451-40-1

If you want to learn more about this compound(2,6-Dichloropurine)Application of 5451-40-1, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(5451-40-1).

Sisulins, Andrejs; Bizdena, Erika; Turks, Maris; Novosjolova, Irina published the article 《2,6-bis[4-(4-butylphenyl)-1H-1,2,3-triazol-1-yl]-9-dodecyl-9H-purine》. Keywords: butylphenyl triazolyl dodecyl purine preparation; diazido dodecyl purine butyl phenylacetylene dipolar cycloaddition copper catalyst.They researched the compound: 2,6-Dichloropurine( cas:5451-40-1 ).Application of 5451-40-1. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:5451-40-1) here.

Target 2,6-bis[4-(4-butylphenyl)-1H-1,2,3-triazol-1-yl]-9-dodecyl-9H-purine has been prepared via a Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction between 2,6-diazido-9-dodecyl-9H-purine and 4-n-butyl(phenylacetylene) in a 29% yield. The obtained compound was fully characterized by NMR, IR and HRMS.

If you want to learn more about this compound(2,6-Dichloropurine)Application of 5451-40-1, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(5451-40-1).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Get Up to Speed Quickly on Emerging Topics: 5451-40-1

If you want to learn more about this compound(2,6-Dichloropurine)Recommanded Product: 5451-40-1, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(5451-40-1).

In organic chemistry, atoms other than carbon and hydrogen are generally referred to as heteroatoms. The most common heteroatoms are nitrogen, oxygen and sulfur. Now I present to you an article called Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell disease, published in 2021-01-01, which mentions a compound: 5451-40-1, mainly applied to fetal Hb inducer beta thalassemia sickle cell disease; Fetal hemoglobin; Inducer; Sickle cell disease; β-Thalassemia, Recommanded Product: 5451-40-1.

Reactivation of fetal Hb (HbF) expression by therapeutic agents has been suggested as an alternative treatment to modulate anemia and the related symptoms of severe β-thalassemia and sickle cell disease (SCD). Hydroxyurea (HU) is the first US FDA-approved HbF inducer for treating SCD. However, approx. 25% of the patients with SCD do not respond to HU. A previous study identified TN1 (1) as a small-mol. HbF inducer. However, this study found that the poor potency and oral bioavailability of compound 1 limits the development of this inducer for clin. use. To develop drug-like compounds, further structure-activity relationship studies on the purine-based structure of 1 were conducted. Herein, we report our discovery of a more potent inducer, compound 13a, that can efficiently induce γ-globin gene expression at non-cytotoxic concentrations The mol. mechanism of 13a, for the regulation HbF expression, was also investigated. In addition, we demonstrated that oral administration of 13a can ameliorate anemia and the related symptoms in SCD mice. The results of this study suggest that 13a can be further developed as a novel agent for treating hemoglobinopathies, such as β-thalassemia and SCD.

If you want to learn more about this compound(2,6-Dichloropurine)Recommanded Product: 5451-40-1, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(5451-40-1).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

A new application about 288-42-6

If you want to learn more about this compound(Oxazole)Category: oxazolidine, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

Category: oxazolidine. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: Oxazole, is researched, Molecular C3H3NO, CAS is 288-42-6, about STACKED – Solvation Theory of Aromatic Complexes as Key for Estimating Drug Binding. Author is Loeffler, Johannes R.; Fernandez-Quintero, Monica L.; Schauperl, Michael; Liedl, Klaus R..

The use of fragments to biophys. characterize a protein binding pocket and determine the strengths of certain interactions is a computationally and exptl. commonly applied approach. Almost all drug like mols. contain at least one aromatic moiety forming stacking interactions in the binding pocket. In computational drug design, the strength of stacking and the resulting optimization of the aromatic core or moiety is usually calculated using high level quantum mech. approaches. However, as these calculations are performed in a vacuum, solvation properties are neglected. We close this gap by using Grid Inhomogeneous Solvation Theory (GIST) to describe the properties of individual heteroaromatics and complexes and thereby estimate the desolvation penalty. In our study, we investigated the solvation free energies of heteroaromatics frequently occurring in drug design projects in complex with truncated side chains of phenylalanine, tyrosine, and tryptophan. Furthermore, we investigated the properties of drug-fragments crystallized in a fragment-based lead optimization approach investigating PDE-10-A. We do not only find good correlation for the estimated desolvation penalty and the exptl. binding free energy, but our calculations also allow us to predict prominent interaction sites. We highlight the importance of including the desolvation penalty of the resp. heteroaromatics in stacked complexes to explain the gain or loss in affinity of potential lead compounds

If you want to learn more about this compound(Oxazole)Category: oxazolidine, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(288-42-6).

Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem